Most hospitals collect a lot of infection data. Infection control nurses walk the wards with checklists, microbiology issues culture reports, pharmacy dispenses antibiotics and the Hospital Infection Control Committee (HICC) meets every month. Yet in many hospitals these streams live in separate registers, spreadsheets and systems. The data exists, but by the time anyone puts it together the patient has often already been discharged, or the cluster has already grown.
Infection intelligence closes that gap. It is the discipline of turning infection-related data into actionable signals that reach the right person in time to change what happens next, and then following those signals through to escalation, action and governance review.
Why traditional surveillance is not enough
The burden is significant. According to the World Health Organization's first Global Report on Infection Prevention and Control (2022), out of every 100 patients in acute-care hospitals, about 7 in high-income countries and 15 in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their stay, and on average 1 in 10 affected patients dies from it. WHO also estimates that good hand hygiene and other cost-effective IPC practices can prevent a large share of these infections, up to 70%.
Traditional surveillance was designed mainly to count infections, often retrospectively and for reporting. It answers "how many infections did we have last quarter?" That question matters, but it does not answer the questions that prevent harm:
- Which patient on which ward is showing signs of a possible device-associated infection today?
- Is this resistant organism part of a cluster, or an isolated case?
- Has the treating clinician seen the susceptibility result, and does the current antibiotic match it?
- Did the corrective action agreed at last month's committee meeting actually happen?
Data vs. intelligence: the five shifts
1. From periodic counts to continuous signals
Instead of tallying infections at month-end, infection intelligence evaluates bedside observations, device data and culture results continuously against agreed surveillance definitions (such as the CDC/NHSN criteria). A possible case gets flagged for review while the patient is still in the bed.
2. From isolated departments to a connected loop
Infection prevention, clinical microbiology and antimicrobial stewardship are usually run as separate workstreams. Each holds part of the picture. Intelligence comes from connecting them, so that an IPC observation links to a culture, the culture links to a prescription, and the prescription links to a stewardship review.
3. From reports to alerts and escalation
A finding that sits in a report nobody reads achieves nothing. An intelligence approach defines who must be told, how fast, and what happens if they do not respond, whether that is the duty infection control nurse, the treating clinician or the microbiologist.
4. From activity to accountability
Audits and observations generate actions. Intelligence tracks those actions to closure, with owners and due dates, so the committee reviews outcomes rather than intentions.
5. From hindsight to learning
Every investigated case should feed back into training, policy and the next cycle of surveillance. This is the closing the loop that clinical governance frameworks repeatedly ask for.
What infection intelligence is not
It is not a replacement for clinical judgement, and software alone does not prevent infections. People do: nurses following bundles, clinicians reviewing therapy, leaders resourcing IPC teams. Infection intelligence makes those people faster and better informed, and gives the organisation a reliable memory of what was found and what was done. Any automated flag should be treated as a prompt for expert review, not a diagnosis.
The building blocks
- Structured surveillance at the bedside: mobile-first capture of device days, bundle compliance, vitals and symptoms.
- Rules-based detection that applies recognised surveillance definitions consistently.
- Microbiology integration: culture and susceptibility results structured, interpreted against current breakpoints and linked to the patient.
- Live antibiograms that reflect the hospital's own resistance patterns.
- Stewardship workflows: time-outs, approvals and consumption metrics such as DDD and DOT.
- Governance tooling: KPIs, committee dossiers and tracked actions.
Why hospitals choose Ibhar
Ibhar was built around this idea: turning infection data into intelligence that teams can act on, from ward to board. Ibhar is the infection intelligence platform for infection prevention and control (IPC), antimicrobial stewardship (AMS) and antimicrobial resistance (AMR). Hospitals from India to the Middle East use it, and it works alongside Epic, Oracle Health (Cerner) and InterSystems.
- 800+ hospitals with Ibhar implementation experience.
- Technology partner to the JIPMER-led national antibiogram study across 75+ hospitals.
- Recognised by the Health Innovation Exchange at the United Nations General Assembly.
Hospitals record infections. Few learn from them. Infection intelligence is how they start.
To see what Ibhar could do for your hospital, talk to our team.